Product Information
LAMIVUDINE HBV 100 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $8.1597 per EA under NDC 31722075260. Its NADAC has been published 517 times since Jun 4, 2014.
FDA first approved this application on Jan 2, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722075260
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA203260FDA Approved
1/2/2014
TE Code
AB
On Market Since
1/2/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE HBV 100 MG TABLET has been published 517 times since Jun 4, 2014, and over the history we have for it it has declined 23.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1597 per EA |
|---|---|
| All-time high | $11.2082 (Nov 12, 2014) |
| All-time low | $1.5548 (May 17, 2023) |
| Median price | $3.0295 |
| Average price | $4.7356 |
| Largest weekly change | +160.1% (Sep 18, 2024) |
| Weeks tracked | 517 |
| Tracking since | Jun 4, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+424.8%
5Y
+199.7%
All
-23.9%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE HBV 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE HBV 100 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $8.1597 per EA (NDC 31722075260), effective Nov 13, 2024.
How has the price of LAMIVUDINE HBV 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE HBV 100 MG TABLET has declined 23.9%. It has been tracked across 517 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE HBV 100 MG TABLET?
Since Jun 4, 2014, the NADAC for LAMIVUDINE HBV 100 MG TABLET has ranged from a low of $1.5548 (May 17, 2023) to a high of $11.2082 (Nov 12, 2014), with a median of $3.0295 per EA.
Are there cheaper alternatives to LAMIVUDINE HBV 100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LAMIVUDINE HBV 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMIVUDINE HBV 100 MG TABLET?
LAMIVUDINE HBV 100 MG TABLET (NDC 31722075260) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.